Evidence check: CYP1A2 in the context of Stress

The link between CYP1A2 and stress is indirect, mediated by caffeine metabolism. CYP1A2 is the primary enzyme that breaks down caffeine. Genetic variants (e.g., rs762551) classify individuals as fast or slow caffeine metabolizers. Slow metabolizers experience prolonged caffeine exposure, which can amplify cortisol release and heighten anxiety or stress responses. However, the evidence is limited: no robust clinical trials directly connect CYP1A2 genotype to chronic stress or HPA axis recovery. Most support comes from mechanistic plausibility and small observational studies. Consumer DNA tests like MyBody-X may report this variant, but the real-world impact on daily stress is uncertain. High caffeine intake in slow metabolizers may disrupt sleep and increase tension. Be cautious of overblown claims: a single gene test cannot diagnose stress levels. For persistent stress, seek medical evaluation and use genetic data as a minor piece of the puzzle, not a standalone answer.